Read More

MediPharm Labs signs agreement with Remidose for cannabis inhalers, sprays

MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) entered into a licensing agreement with Remidose Aerosols to buy exclusive rights for advanced cannabis products including inhalers and sublingual sprays. MediPharm said the deal is an immediate revenue opportunity as current Remidose customers will be serviced through MediPharm starting in August. “These …